Vertex Pharmaceuticals Inc

VRTX

Equity

ISIN null / Valor 983327

NASDAQ (2026-10-06)

USD 502.31-0.24%

Vertex Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Vertex Pharmaceuticals Inc. is a global biotechnology firm focused on developing and commercializing innovative treatments for serious diseases. With headquarters in Boston and London, the company operates a network of research and development sites along with commercial offices worldwide. Vertex Pharmaceuticals is known for its commitment to scientific innovation, aiming to address unmet medical needs in various therapeutic areas. While the source does not specify the diseases or treatments the company focuses on, Vertex has gained recognition for its work in cystic fibrosis (CF) and other life-threatening conditions, developing a range of medications that have significantly impacted patients' lives. The company's global presence and dedication to transformative treatments underscore its role in the biotech industry, striving to improve health outcomes for patients facing serious diseases.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.7%1Y

39.3%3Y

178%5Y

Performance

28.6%1Y

30.5%3Y

29.4%5Y

Volatility